The show will be a part of the India Pharma Week, a marquee celebration catering to every need of the pharma community attendees
The dividend cheque of Rs. 9.93 crore for the Ministry of Ayush was handed over to Sonowal
Investment in R&D was Rs. 337.6 crore (8.3% of sales) for Q2 FY2023 as compared to Rs. 330 crore (8.2% of sales) for Q2 FY2022.
The core of “LANXESS Biosecurity Solutions” is a portfolio of scientifically formulated, highly effective and versatile biocidal products
The USFDA has determined that the inspection classification of the facility is Voluntary Action Indicated (VAI)
The laboratory is equipped to perform high-volume diagnostic testing services
The voluntary program is the first time the FDA will allow excipient manufacturers to obtain review of certain novel excipients prior to their use in drug formulations.
NFIL’s ambition is to reach revenues of US$100mn from CDMO by FY25.
CEPI will provide up to US$40 million in initial funding to support the development of mRNA-vaccine candidates against Lassa Fever virus
Subscribe To Our Newsletter & Stay Updated
